CIT joins “ScreenTox” stem cell development project
French contract research organisation (CRO) CIT will work on in vitro toxicity testing for pharmaceutical and cosmetic ingredients as the newest member of the European “ScreenTox” network.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs